Status:
COMPLETED
Clinical Study Of Migraine Evolution
Lead Sponsor:
GlaxoSmithKline
Conditions:
Migraine Headache
Eligibility:
All Genders
18+ years
Brief Summary
Understanding the speed at which migraine headaches develop is of importance to patients. Determining the proportions in which different headache pain build-up occurs, may provide health care practiti...
Eligibility Criteria
Inclusion
- Subject is outpatient.
- Subject has a diagnosis of migraine with/without aura according to IHS criteria, of at least 1 years duration.
- Subject is able to comprehend the study procedures and to comply with study requirements.
Exclusion
- Subject has other chronic pain condition(s) not associated with migraine
- Subject is unable to understand the schedule/questionnaire.
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00460005
Start Date
January 1 2006
Last Update
April 15 2008
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Clinical Trials Call Centre
Calgary, Alberta, Canada, T2N 2T9
2
GSK Clinical Trials Call Centre
Richmond, British Columbia, Canada, V6X 1A3
3
GSK Clinical Trials Call Centre
Vancouver, British Columbia, Canada, V5Z 1M9
4
GSK Clinical Trials Call Centre
Saint John, New Brunswick, Canada, E2L 4L2